Mutations of the NS5B region in patients with chronic hepatitis C virus genotype 1b infection: Response to interferon alfa 2b and ribavirin

被引:0
|
作者
Sugihara, K [1 ]
Orito, E [1 ]
Tanaka, Y [1 ]
Ohno, T [1 ]
Kato, T [1 ]
Mizokami, M [1 ]
机构
[1] Nagoya City Univ, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:331A / 331A
页数:1
相关论文
共 50 条
  • [21] Combination therapy with interferon α-2b/ribavirin plus lactoferrin for chronic hepatitis C in patients with genotype 1b and high viremia.
    Goto, K
    Mima, S
    Kumagai, N
    Tsuchimoto, K
    Ishii, K
    Sumino, Y
    Yamauchi, K
    Teraguchi, S
    HEPATOLOGY, 2002, 36 (04) : 591A - 591A
  • [22] Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin
    Yang, SS
    Lai, MY
    Chen, DS
    Chen, GH
    Kao, JH
    LIVER INTERNATIONAL, 2003, 23 (06): : 426 - 433
  • [23] Mutations in NS5A region and et interferon response in hepatitis 1b infected patients
    Halimi, G
    Halfon, P
    Gerolami, V
    Castets, F
    Khiri, H
    Bourliere, M
    Gauthier, AP
    Cartouzou, G
    HEPATOLOGY, 1996, 24 (04) : 144 - 144
  • [24] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Veillon, Pascal
    Payan, Christopher
    Le Guillou-Guillemette, Helene
    Gaudy, Catherine
    Lunel, Francoise
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (08) : 1195 - 1203
  • [25] Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C
    Wada, Yuki
    Tamai, Hideyuki
    Kawashima, Akira
    Shingaki, Naoki
    Mori, Yoshiyuki
    Kawaguchi, Masanori
    Moribata, Kosaku
    Deguchi, Hisanobu
    Ueda, Kazuki
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    GUT AND LIVER, 2014, 8 (04) : 421 - 427
  • [26] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Pascal Veillon
    Christopher Payan
    Hélène Le Guillou-Guillemette
    Catherine Gaudy
    Franoise Lunel
    World Journal of Gastroenterology, 2007, (08) : 1195 - 1203
  • [27] A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background
    Graham, DJ
    Stahlhut, M
    Flores, O
    Olsen, DB
    Hazuda, DJ
    LaFemina, RL
    Ludmerer, SW
    ANTIVIRAL RESEARCH, 2006, 69 (01) : 24 - 30
  • [28] ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Honda, Takashi
    Ishigami, Masatoshi
    Nakano, Isao
    Goto, Hidemi
    HEPATOLOGY, 2010, 52 (04) : 772A - 772A
  • [29] Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
    Enomoto, N
    Sakuma, I
    Asahina, Y
    Kurosaki, M
    Murakami, T
    Yamamoto, C
    Ogura, Y
    Izumi, N
    Marumo, F
    Sato, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02): : 77 - 81
  • [30] Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin
    Hung, CH
    Lee, CM
    Lu, SN
    Lee, JF
    Wang, JH
    Tung, HD
    Chen, TM
    Hu, TH
    Chen, WJ
    Changchien, CS
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (02) : 87 - 94